Abstract 5634: The single mouse trial format predicts the sensitivity towards checkpoint inhibitor treatment in NSCLC PDX models in HuCD34NCG/CRL mice, an innovative triple immune deficient mouse strain
Authors: Julia Schüler, Jenny Rowe, Eva Oswald, Stephen Festin
Published: 2020-09-04
DOI:
10.1158/1538-7445.am2020-5634
Source:
Full article
Abstract
Abstract